Back

Plasma CCL3 predicts adverse heart failure outcomes in patients with arrhythmogenic cardiomyopathy

29 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Mechanisms and management of cardiomyopathies Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Tianshuo Yang

Fuwai Hospital, CAMS and PUMC, Beijing (China)

6 More presentations in this session

Presentation thumbnail
Psychiatric disorders in Takotsubo syndrome: clinical profiles and outcomes
Doctor D. Di Vece (Greifswald, DE)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes of treatment strategies for ischemic cardiomyopathy, a network meta-analysis
Mr D. Perez Camargo (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Racial differences in obstetric complications associated with peripartum cardiomyopathy and time to presentation
Miss K. Sompel (Aurora, US)
Abstract Slides Video
Presentation thumbnail
Myocardial work impact in the evaluation of advanced heart failure
Doctor L. Martini (Siena, IT)
Abstract Slides Video
Presentation thumbnail
Identifying racially inequities driven by social determinants of health in US peripartum cardiomyopathy patients and the influence on time to presentation
Miss K. Sompel (Aurora, US)
Abstract Slides Video

Access the full session

Session thumbnail
Mechanisms and management of cardiomyopathies

The Event

Event poster

ESC Congress 2025

29 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Session
Biomarkers in cardiomyopathies: recent advances
thumbnail
Congress Presentation
Increased serum PRO-C3 is associated with heart failure worsening in hypertensive patients with heart failure
thumbnail
Congress Presentation
Inflammation and Fibrosis Markers Predict Adverse Outcomes in Arrhythmogenic Cardiomyopathy: An Integrated Multiomics Study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources